KYNU and CYP1B1, an important downstream target of AhR activation, were highly upregulated in the same samples, suggesting their potential roles in BrCa pathology and potentially responsible for poor prognosis29. The gene discussed is CYP1B1; the disease is invasive breast carcinoma.